New treatment option for Opioid Agonist Treatment
Official title Mobile Platform for Optimizing Wellness and Engagement in Recovery
ClinicalTrials.gov ID: NCT07178990
What this study is testing
- What it's testing
- This pilot study addresses the urgent public health crisis of co-occurring opioid and alcohol use disorders (OUD-AUD), leading causes of mortality in the United States, by testing a scalable digital contingency management (CM) treatment among Medicaid beneficiaries. The study aims to evaluate the feasibility and acceptability of digital CM for OUD-AUD recovery, while also planning for broader implementation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 63
You may be able to join if
- Participants must be enrolled in the Michigan Medicaid program
- Opioid agonist treatment (OAT): Participants must have initiated OAT with buprenorphine or methadone
- Participants must have an OAT prescription and Alcohol use disorder (AUD) based on self-report measure during screening
- Participants must have regular access to a working smartphone and internet connection.
- Participants must have a reliable mailing address to receive study supplies (e.g., salivary drug tests).
You likely can't join if
- Primary Medicare Coverage: Individuals that are dual-eligible for Medicaid and Medicare and aged 65 or older, due to limited availability of Medicaid...
- Individuals that cannot voluntarily provide informed consent themselves for any reason, including legal incompetency
- Individuals with substantial cognitive impairment that would interfere with study participation
- Individuals unable to read or understand English
- Individuals experiencing active suicidality or psychosis.
- Individuals with a planned admission to residential treatment or incarceration during the study period.
The study team makes the final eligibility decision.
Where it's taking place
- Ann Arbor, Michigan, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 63 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ann Arbor, Michigan, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.